109 related articles for article (PubMed ID: 10214370)
21. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
Macdonald KG; Doan B; Kelner M; Taylor KM
CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
[TBL] [Abstract][Full Text] [Related]
22. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
Sherman KA; Kasparian NA; Mireskandari S
Psychooncology; 2010 Jan; 19(1):1-11. PubMed ID: 19472298
[TBL] [Abstract][Full Text] [Related]
23. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
[TBL] [Abstract][Full Text] [Related]
24. Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer.
Merajver SD; Petty EM
Clin Lab Med; 1996 Mar; 16(1):139-67. PubMed ID: 8867588
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
Radulović S; Branković-Magić M; Janković R; Ristanović M
Srp Arh Celok Lek; 2003; 131(7-8):345-50. PubMed ID: 14692152
[TBL] [Abstract][Full Text] [Related]
26. Psychosocial aspects of genetic testing for hereditary breast and/or ovarian cancer, 5th international meeting. Leuven, Belgium, June 29-30, 1998. Abstracts.
Genet Couns; 1998; 9(4):319-326. PubMed ID: 10206652
[No Abstract] [Full Text] [Related]
27. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer.
Gutiérrez-Enríquez S; de la Hoya M; Martínez-Bouzas C; Sanchez de Abajo A; Ramón y Cajal T; Llort G; Blanco I; Beristain E; Díaz-Rubio E; Alonso C; Tejada MI; Caldés T; Diez O
Breast Cancer Res Treat; 2007 May; 103(1):103-7. PubMed ID: 17063271
[TBL] [Abstract][Full Text] [Related]
28. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
Maheu C; Thorne S
Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
30. Psychological impact of receiving a BRCA1/BRCA2 test result.
Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
[TBL] [Abstract][Full Text] [Related]
31. [The chance of breast carcinoma and related carcinomas in a positive family anamnesis. Landelijke Werkgroep Erfelijk Mammacarcinoom van de Stichting Opsporing Erfelijke Tumoren].
Oosterwijk JC; Sijmons RH; Menko FH; Chorus AM; Rookus MA
Ned Tijdschr Geneeskd; 1995 Mar; 139(9):423-8. PubMed ID: 7891763
[No Abstract] [Full Text] [Related]
32. [Clinical counseling and care of women with genetic predisposition to breast and ovarian carcinoma].
Schmutzler RK; Kempe A; Kiechle M; Beckmann MW
Dtsch Med Wochenschr; 1999 May; 124(18):563-6. PubMed ID: 10356583
[No Abstract] [Full Text] [Related]
33. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
Gayther SA; Warren W; Mazoyer S; Russell PA; Harrington PA; Chiano M; Seal S; Hamoudi R; van Rensburg EJ; Dunning AM; Love R; Evans G; Easton D; Clayton D; Stratton MR; Ponder BA
Nat Genet; 1995 Dec; 11(4):428-33. PubMed ID: 7493024
[TBL] [Abstract][Full Text] [Related]
34. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond.
Holtzman NA
J Natl Cancer Inst Monogr; 1995; (17):95-7. PubMed ID: 8573464
[No Abstract] [Full Text] [Related]
35. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
Shah MR
Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
[TBL] [Abstract][Full Text] [Related]
36. Congress report of the seventh international meeting on psychosocial aspects of genetic testing for hereditary breast and/or ovarian cancer (HBOC) and hereditary non-polyposis colorectal cancer (HNPCC).
Jordan J; Evans G; Evers-Kiebooms G; Julian-Reynier C; Kash K; Watson M
Psychooncology; 2002; 11(6):536-9. PubMed ID: 12476435
[No Abstract] [Full Text] [Related]
37. Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer.
de Wit AC; Meijers-Heijboer EJ; Tibben A; Frets PG; Klijn JG; Devilee P; Niermeijer MF
Lancet; 1994 Jul; 344(8916):197. PubMed ID: 7912795
[No Abstract] [Full Text] [Related]
38. Understanding emotional responses to breast/ovarian cancer genetic risk assessment: an applied test of a cognitive theory of emotion.
Phelps C; Bennett P; Brain K
Psychol Health Med; 2008 Oct; 13(5):545-58. PubMed ID: 18942008
[TBL] [Abstract][Full Text] [Related]
39. Genetic testing in breast/ovarian cancer (BRCA1) families.
Watson M; Murday V; Lloyd S; Ponder B; Averill D; Eeles R
Lancet; 1995 Aug; 346(8974):583. PubMed ID: 7658809
[No Abstract] [Full Text] [Related]
40. Psychosocial dimensions of BRCA testing: an overshadowed issue.
Brédart A; Autier P; Riccardo A; Audisio A; Geraghty JG
Eur J Cancer Care (Engl); 2001 Jun; 10(2):96-9. PubMed ID: 11829055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
